Pars planitis and Fall

Summary:

Fall is found among people with Pars planitis, especially for people who are female, 60+ old.

The study analyzes which people have Fall with Pars planitis. It is created by eHealthMe based on reports of 334 people who have Pars planitis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Pars planitis?

Pars planitis (inflammation of the pars plana, a part of the ciliary body) is found to be associated with 1,365 drugs and 1,547 conditions by eHealthMe. Check the latest studies of Pars planitis.

What is Fall?

Fall is found to be associated with 3,269 drugs and 3,757 conditions by eHealthMe. Check the latest studies of Fall.



On Jun, 19, 2026

334 people who have Pars Planitis and Fall are studied.

Would you have Fall when you have Pars planitis?

Gender of people who have Pars Planitis and experienced Fall *:

  • female: 82.13 %
  • male: 17.87 %

Age of people who have Pars Planitis and experienced Fall *:

  • 0-1: 0.0 %
  • 2-9: 1.27 %
  • 10-19: 2.12 %
  • 20-29: 0.0 %
  • 30-39: 2.9699999999999998 %
  • 40-49: 5.93 %
  • 50-59: 20.34 %
  • 60+: 67.37 %

Common co-existing conditions for these people *:

  1. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 124 people, 37.13%
  2. Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 76 people, 22.75%
  3. Arthritis (form of joint disorder that involves inflammation of one or more joints): 58 people, 17.37%
  4. High Blood Pressure: 38 people, 11.38%
  5. Ankylosing Spondylitis (type of arthritis affecting the spine): 26 people, 7.78%
  6. High Blood Cholesterol: 23 people, 6.89%
  7. Pain: 21 people, 6.29%
  8. Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 16 people, 4.79%
  9. Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 12 people, 3.59%
  10. Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 12 people, 3.59%

Common drugs taken by these people *:

  1. Humira: 267 people, 79.94%
  2. Remicade: 80 people, 23.95%
  3. Orencia: 76 people, 22.75%
  4. Pantoprazole: 76 people, 22.75%
  5. Methotrexate: 74 people, 22.16%
  6. Actemra: 72 people, 21.56%
  7. Arava: 70 people, 20.96%
  8. Enbrel: 70 people, 20.96%
  9. Ferrous Fumarate: 69 people, 20.66%
  10. Prednisone: 68 people, 20.36%

Common symptoms for these people *:

  1. Fatigue (feeling of tiredness): 121 people, 36.23%
  2. Pain: 117 people, 35.03%
  3. Joint Pain: 110 people, 32.93%
  4. Pain In Extremity: 93 people, 27.84%
  5. Osteoporosis (bones weak and more likely to break): 91 people, 27.25%
  6. Drug Ineffective: 85 people, 25.45%
  7. Rashes (redness): 83 people, 24.85%
  8. Impaired Healing: 82 people, 24.55%
  9. Arthropathy: 81 people, 24.25%
  10. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 81 people, 24.25%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Fall?

- Check whether Fall is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Fall:

  • Fall (3,269 drugs)

All the conditions that are associated with Fall:

  • Fall (3,757 conditions)

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Fall and Pars planitis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: